The present study not only supports the importance of GSK3 kinases (including GSK3α and GSK3β) as critical nodes in the progression of Alzheimer's disease [40], but also emphasizes the central role of GSK3 in regulating intracellular trafficking [41], [42], [43]. Here, GSK3A is linked to early-onset autosomal dominant Alzheimer disease.